CalciMedica Analyst Price Targets

Wall Street analyst price targets and consensus rating for CalciMedica (CALC).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

4Buy

1Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$74Upside to Avg. PT+4705.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 20, 2026	Guggenheim	Vamil Divan	Initiate	Buy	$45
Mar 5, 2026	Oppenheimer	Leland Gershell	PT Cut	Outperform	$100→$50
Jan 29, 2026	HC Wainwright & Co.	Joseph Pantginis	Downgrade	Buy→Neutral	—
May 15, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$80
Apr 1, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$80
Mar 4, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$80
Dec 17, 2024	LUCID CAPITAL MARKETS	Dev Prasad	Initiate	Buy	$65
Nov 14, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$80
Nov 4, 2024	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$100→$80
Aug 13, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
Jul 10, 2024	Oppenheimer	Leland Gershell	PT Raise	Outperform	$70→$100
Jul 9, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
Jun 27, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
May 14, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
Apr 1, 2024	Oppenheimer	Leland Gershell	Maintained	Outperform	$70
Apr 1, 2024	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$100
Mar 13, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
Feb 16, 2024	JonesTrading	Catherine Novack	Initiate	Buy	$110
Feb 13, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$100
Jan 29, 2024	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$100

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9

Guggenheim analyst Vamil Divan initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on CalciMedica, Lowers Price Target to $10

Oppenheimer analyst Leland Gershell maintains CalciMedica (NASDAQ:CALC) with a Outperform and lowers the price target from $20 to $10.

Benzinga Newsdesk

This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Avi Kapoor

PRO
HC Wainwright & Co. Downgrades CalciMedica to Neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades CalciMedica (NASDAQ:CALC) from Buy to Neutral.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates CalciMedica (NASDAQ:CALC) with a Buy and maintains $16 price target.

Benzinga Newsdesk

CalciMedica Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

CalciMedica Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Guggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9

PRO
Oppenheimer Maintains Outperform on CalciMedica, Lowers Price Target to $10

This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

PRO
HC Wainwright & Co. Downgrades CalciMedica to Neutral

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

People Also Watch

People Also Watch

CalciMedica Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

CalciMedica Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROGuggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9

PROOppenheimer Maintains Outperform on CalciMedica, Lowers Price Target to $10

This CalciMedica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

PROHC Wainwright & Co. Downgrades CalciMedica to Neutral

PROHC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

PROHC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

People Also Watch

People Also Watch

PRO
Guggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9

PRO
Oppenheimer Maintains Outperform on CalciMedica, Lowers Price Target to $10

PRO
HC Wainwright & Co. Downgrades CalciMedica to Neutral

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on CalciMedica, Maintains $16 Price Target